Crystal's MCW Coder Hub🧬CPT Code 38900 - Intraoperative Identification of Sentinel Lymph Node(s)
Quick Reference
wRVU: 1.50 | Global Period: ZZZ (Add-on) | Assistant Payable: ❌ No | Modifier 51 Exempt: ✅ Yes | Always Reported With a Parent Code
📋 Clinical Description
CPT Code 38900 is an add-on code (+38900) that describes the intraoperative identification and mapping of sentinel lymph node(s) using one or more of the following modalities:
- Non-radioactive dye injection - e.g., isosulfan blue (Lymphazurin), methylene blue, or indocyanine green (ICG) with near-infrared imaging
- Radioactive tracer injection - e.g., technetium-99m sulfur colloid (Tc-99m) injected preoperatively in nuclear medicine
- Handheld gamma (Geiger) counter - intraoperative use to audibly detect radioactive uptake in nodal tissue
- Intraoperative lymphatic mapping - real-time visualization of lymphatic drainage pathways
The sentinel lymph node (SLN) is defined as the first node(s) in the regional lymphatic basin to which a primary tumor drains. The underlying principle is that if the SLN is histologically negative for metastatic disease, the remaining regional nodes are highly likely to be negative as well — sparing the patient a full lymphadenectomy and its associated morbidity (lymphedema, neurovascular injury, prolonged recovery).
This technique was pioneered in the management of melanoma and breast cancer and has since been validated and adopted across multiple oncologic specialties including vulvar, penile, cervical, endometrial, and select head and neck malignancies.
Add-On Code Rules
CPT 38900 is never reported alone. It must be appended to the primary surgical procedure being performed (e.g., excision of malignant lesion, mastectomy, wide local excision). By definition as an add-on code, it is exempt from modifier -51 and does not carry its own global period — it inherits the global period of the parent code.
🔬 Procedural Technique Overview
Step 1 - Preoperative Lymphoscintigraphy (if Tc-99m used)
- Technetium-99m sulfur colloid is injected perilesionally or intradermally by nuclear medicine 1-4 hours preoperatively
- Gamma camera imaging maps drainage to the first echelon nodal basin
- The skin is marked over the hot node(s) for intraoperative guidance
- Separately reported by nuclear medicine using CPT 78195 (lymphatics and lymph nodes imaging)
Step 2 - Intraoperative Dye Injection (if blue dye used)
- Isosulfan blue or methylene blue is injected perilesionally at the start of the surgical case
- The dye travels via afferent lymphatics, staining the sentinel node(s) blue within minutes
- ICG with near-infrared fluorescence imaging is an increasingly used alternative offering real-time visualization
Step 3 - Intraoperative Mapping and Identification
- The gamma probe is swept across the operative field to detect Tc-99m radioactivity (audible clicks)
- The dissection is guided toward the hottest node(s) and/or blue-stained node(s)
- The SLN is defined operationally as any node with >10% of the ex vivo radioactivity count of the hottest node and/or any visually blue-stained node
- All identified SLNs are excised
Step 4 - Intraoperative Pathology (Separate Service)
- Frozen section or touch prep cytology may be performed intraoperatively
- If positive: immediate conversion to complete regional lymphadenectomy in some protocols
- Final pathology including immunohistochemistry (IHC) for micrometastasis detection: reported separately
✅ Procedure Includes
- Injection of non-radioactive dye(s) (isosulfan blue, methylene blue, ICG) if utilized
- Intraoperative use of handheld gamma counter/probe if utilized
- Real-time intraoperative lymphatic mapping and visualization
- Identification and surgical excision of the sentinel lymph node(s)
- Wound management within the sentinel node biopsy site (part of parent procedure wound closure)
- All components of the SLN identification service regardless of which combination of modalities is used (dye alone, probe alone, or both — same code)
❌ Excludes / Do Not Report Separately
| Code | Description | Relationship to 38900 |
|---|---|---|
| 78195 | Lymphatics and lymph nodes imaging (lymphoscintigraphy) | Preoperative nuclear medicine mapping — separately reportable by nuclear medicine/radiology; NOT included in 38900 |
| 38500-38542 | Open lymph node biopsy / dissection codes | Parent codes; 38900 is reported in addition to these, not instead of |
| 19301-19307 | Mastectomy procedures | Common parent codes for breast cancer SLN mapping; 38900 adds on |
| 38740 / 38745 | Axillary lymphadenectomy | If full axillary dissection is performed, 38900 is not separately reported — it is subsumed by the full lymphadenectomy |
| 38720 / 38724 | Radical / modified radical neck dissection | Comprehensive nodal dissection subsumes sentinel node mapping |
| 38792 | Injection procedure for nuclear medicine (preoperative tracer injection) | Radiopharmaceutical injection for lymphoscintigraphy, when performed by the operating surgeon preoperatively — distinct from 38900 which covers intraoperative use |
Critical Bundling Rule
If the sentinel node is found to be positive intraoperatively and the surgeon immediately proceeds to a complete regional lymphadenectomy (e.g., 38740 or 38745), 38900 is bundled into the complete dissection and should not be separately reported. The comprehensive lymphadenectomy subsumes the SLN identification service. Report the lymphadenectomy code only.
However, if the SLN biopsy is the only nodal procedure performed (SLN negative, no completion lymphadenectomy), 38900 is correctly reported as an add-on to the primary excision.
🌳 Code Tree - Lymph Nodes and Lymphatic Channels
CPT 38300-38999 Surgery: Lymph Nodes and Lymphatic Channels
│
├── 38500-38542 Biopsy / Excision
│ ├── 38500 Open, superficial
│ ├── 38505 Needle biopsy, superficial
│ ├── 38510 Open, deep cervical
│ ├── 38520 Deep cervical + scalene fat pad
│ ├── 38525 Open, deep axillary
│ ├── 38530 Internal mammary node(s)
│ └── 38542 Dissection, deep jugular node(s)
│
├── 38700-38724 Neck Dissection
│ ├── 38700 Suprahyoid lymphadenectomy
│ ├── 38720 Radical neck dissection
│ └── 38724 Modified radical neck dissection
│
├── 38740-38746 Axillary / Thoracic
│ ├── 38740 Axillary lymphadenectomy, superficial
│ ├── 38745 Axillary lymphadenectomy, complete
│ └── 38746 Thoracic lymphadenectomy, regional
│
├── ▶▶ +38900 ◀◀ Intraoperative ID of sentinel node(s) - ADD-ON ← YOU ARE HERE
│ └── Always reported with a parent excision/procedure code
│
└── 78195 78195 Lymphatics imaging (lymphoscintigraphy) — Radiology/Nuc Med
💰 RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU (wRVU) | 1.50 |
| Global Period | ZZZ - Add-on code (inherits parent global) |
| Bilateral Indicator | 9 - Does not apply |
| Assistant Surgeon (Modifier 80) | ❌ Not Payable |
| Co-Surgeon | ❌ Not applicable |
| Team Surgery | ❌ Not applicable |
| Modifier -51 Exempt | ✅ Yes — add-on codes are always exempt |
| PC/TC Split | ❌ No — procedure code only |
| Anesthesia | Performed under anesthesia used for parent procedure; not separately reported |
Reimbursement Note
Because 38900 is an add-on code, it is never subject to the multiple procedure reduction (modifier -51 rules). It is paid at the full allowed amount in addition to the parent code’s payment. Medicare and most commercial payers follow this convention. Confirm with individual payer contracts, as some manage care plans have carved-out or bundled SLN services into the primary surgical payment.
🏷️ Modifier Reference
| Modifier | Name | When to Apply with 38900 |
|---|---|---|
| -51 | Multiple Procedures | Never — add-on codes are modifier -51 exempt by definition |
| -59 | Distinct Procedural Service | Rarely needed; may be applicable when SLN mapping is performed on a separate nodal basin from the parent procedure’s primary operative site in the same session |
| -52 | Reduced Services | If SLN identification attempted but sentinel node could not be identified (non-visualization); document failed mapping attempt thoroughly |
| -53 | Discontinued Procedure | If procedure abandoned due to adverse drug reaction (e.g., isosulfan blue anaphylaxis) or patient instability |
Modifier -52 for Failed Mapping
Non-visualization (failure to identify a sentinel node) occurs in approximately 1-5% of cases due to obstructed lymphatic channels, prior surgery, obesity, or failed radiotracer uptake. When 38900 is reported with modifier -52 for failed identification, documentation must clearly state: the modalities attempted, the reason for failure, and that no sentinel node was excised. Some payers may deny 38900--52 entirely; check LCD coverage policies.
🩺 Common ICD-10-CM Pairings
Breast Cancer
| ICD-10 Code | Description | HCC? | HCC Category (v28) | Notes |
|---|---|---|---|---|
| C50.911 | Malignant neoplasm of unspecified site of right female breast | ✅ Yes | Cancer HCC | Most common indication; specify laterality and quadrant when documented |
| C50.912 | Malignant neoplasm of unspecified site of left female breast | ✅ Yes | Cancer HCC | Specify quadrant per pathology/imaging |
| C50.011 | Malignant neoplasm of nipple and areola, right female breast | ✅ Yes | Cancer HCC | Paget’s disease variant |
| C50.411 | Malignant neoplasm of upper outer quadrant, right female breast | ✅ Yes | Cancer HCC | Most anatomically common subsite |
| C50.412 | Malignant neoplasm of upper outer quadrant, left female breast | ✅ Yes | Cancer HCC | Mirror-image code; specify laterality |
Melanoma
| ICD-10 Code | Description | HCC? | HCC Category (v28) | Notes |
|---|---|---|---|---|
| C43.9 | Malignant melanoma of skin, unspecified | ✅ Yes | Cancer HCC | Use most specific subsite when documented |
| C43.30 | Malignant melanoma of unspecified part of face | ✅ Yes | Cancer HCC | Cervical SLN basin common |
| C43.51 | Malignant melanoma of anal skin | ✅ Yes | Cancer HCC | Inguinal SLN basin |
| C43.60 | Malignant melanoma of unspecified upper limb, including shoulder | ✅ Yes | Cancer HCC | Axillary SLN basin |
| C43.70 | Malignant melanoma of unspecified lower limb, including hip | ✅ Yes | Cancer HCC | Inguinal SLN basin |
| C44.91 | Unspecified malignant neoplasm of skin, unspecified | ✅ Yes | Cancer HCC | Use when histology not yet confirmed; update when final path available |
Gynecologic Malignancies
| ICD-10 Code | Description | HCC? | HCC Category (v28) | Notes |
|---|---|---|---|---|
| C54.1 | Malignant neoplasm of endometrium | ✅ Yes | Cancer HCC | SLN mapping increasingly standard in endometrial CA staging |
| C56.1 | Malignant neoplasm of right ovary | ✅ Yes | Cancer HCC | SLN mapping less established but used in select protocols |
| C56.2 | Malignant neoplasm of left ovary | ✅ Yes | Cancer HCC | |
| C51.9 | Malignant neoplasm of vulva, unspecified | ✅ Yes | Cancer HCC | Inguinal SLN; validated technique for vulvar CA |
| C53.9 | Malignant neoplasm of cervix uteri, unspecified | ✅ Yes | Cancer HCC | SLN mapping used in early-stage cervical CA |
Urologic / Other Malignancies
| ICD-10 Code | Description | HCC? | HCC Category (v28) | Notes |
|---|---|---|---|---|
| C61 | Malignant neoplasm of prostate | ✅ Yes | Cancer HCC | Pelvic SLN mapping in prostate CA; evolving evidence base |
| C60.9 | Malignant neoplasm of penis, unspecified | ✅ Yes | Cancer HCC | Inguinal SLN well-validated in penile CA staging |
| C64.1 | Malignant neoplasm of right kidney, except renal pelvis | ✅ Yes | Cancer HCC | Less common SLN indication |
| C67.9 | Malignant neoplasm of bladder, unspecified | ✅ Yes | Cancer HCC | Investigational in select bladder CA protocols |
Thyroid / Head & Neck
| ICD-10 Code | Description | HCC? | HCC Category (v28) | Notes |
|---|---|---|---|---|
| C73 | Malignant neoplasm of thyroid gland | ✅ Yes | Cancer HCC | SLN mapping used in differentiated thyroid CA with lateral neck involvement |
| C07 | Malignant neoplasm of parotid gland | ✅ Yes | Cancer HCC | Cervical SLN basin |
| C32.9 | Malignant neoplasm of larynx, unspecified | ✅ Yes | Cancer HCC | Head/neck SLN protocols |
Nodal / Secondary Diagnoses
| ICD-10 Code | Description | HCC? | Notes |
|---|---|---|---|
| C77.0 | Secondary malignant neoplasm, lymph nodes of head, face, neck | ✅ Yes - HCC 17 | Code when SLN pathology confirms nodal metastasis |
| C77.3 | Secondary malignant neoplasm, axillary and upper limb nodes | ✅ Yes - HCC 17 | Positive axillary SLN in breast CA |
| C77.4 | Secondary malignant neoplasm, inguinal and lower limb nodes | ✅ Yes - HCC 17 | Positive inguinal SLN in melanoma or vulvar CA |
| Z17.0 | Estrogen receptor positive status | ❌ No | Important secondary for breast CA; influences systemic therapy |
| Z80.3 | Family history of malignant neoplasm of breast | ❌ No | Risk factor documentation |
HCC Coding Note - Confirmed vs. Suspected Metastasis
Code C77.x (secondary malignant neoplasm of lymph nodes) only when the SLN is confirmed positive by pathology. If the procedure is performed for staging purposes and the SLN result is pending or ultimately negative, code only the primary malignancy. Do not assign a secondary malignancy code based on clinical suspicion alone — this is governed by ICD-10-CM Guideline Section I.C.2 on neoplasm coding.
C77.3 (axillary nodes) maps to HCC 17 - Metastatic Cancer and Acute Leukemia in CMS-HCC Model v28, carrying one of the highest RAF weights in the malignancy hierarchy. Accurate capture of confirmed nodal metastasis has significant RAF score and revenue cycle implications in Medicare Advantage populations.
🏥 MS-DRG Considerations (Inpatient)
Inpatient Facility Reminder
In the inpatient DRG setting, CPT 38900 is not used. The ICD-10-PCS equivalent codes are used instead. The MS-DRG is primarily driven by the principal diagnosis and the primary ICD-10-PCS procedure (e.g., mastectomy, excision of tumor). The SLN mapping PCS codes typically do not independently change the DRG but contribute to procedure complexity documentation.
Common Inpatient DRG Assignments by Disease Category
Breast Cancer DRGs
| MS-DRG | Title | GMLOS | Key Driver |
|---|---|---|---|
| 582 | Mastectomy for Malignancy with CC/MCC | ~2.8 days | Malnutrition, infection, dyspnea, DVT as CC/MCC |
| 583 | Mastectomy for Malignancy w/o CC/MCC | ~1.6 days | Clean case; no qualifying comorbidities |
| 584 | Breast Biopsy, Local Excision & Other Breast Procedures with MCC | ~4.2 days | High-severity comorbidity present |
| 585 | Breast Biopsy, Local Excision & Other Breast Procedures with CC | ~2.4 days | Moderate comorbidity |
| 586 | Breast Biopsy, Local Excision & Other Breast Procedures w/o CC/MCC | ~1.2 days | Outpatient-level case occasionally admitted |
Skin / Melanoma DRGs
| MS-DRG | Title | GMLOS | Key Driver |
|---|---|---|---|
| 579 | Other Skin, Subcutaneous Tissue & Breast Procedures with MCC | ~7.6 days | Major complication or comorbidity |
| 580 | Other Skin, Subcutaneous Tissue & Breast Procedures with CC | ~3.8 days | CC present |
| 581 | Other Skin, Subcutaneous Tissue & Breast Procedures w/o CC/MCC | ~1.8 days | Uncomplicated |
Gynecologic Oncology DRGs
| MS-DRG | Title | GMLOS | Key Driver |
|---|---|---|---|
| 743 | Uterine & Adnexa Procedures for Ovarian or Adnexal Malignancy with MCC | ~6.1 days | Endometrial/ovarian CA; SLN mapping commonly added |
| 744 | Uterine & Adnexa Procedures for Ovarian or Adnexal Malignancy with CC | ~3.9 days | |
| 745 | Uterine & Adnexa Procedures for Ovarian or Adnexal Malignancy w/o CC/MCC | ~2.4 days |
CC/MCC Capture Opportunities for Oncology Inpatients
Secondary Diagnosis Code Status Severe malnutrition E43 MCC Moderate malnutrition E44.0 CC Anemia in neoplastic disease D63.0 CC Lymphedema, post-procedural I97.2 CC Surgical site infection T81.40XA CC DVT, lower extremity I82.401 CC Pulmonary embolism I26.09 MCC Dehydration E86.0 CC [!note]
Always ensure attending documentation clinically supports each secondary diagnosis before coding. Issue a query when documentation is ambiguous or incomplete.
🔧 ICD-10-PCS Equivalents (Inpatient Facility Coding)
When SLN mapping is performed in the inpatient setting, the following ICD-10-PCS codes may apply. The specific code depends on the body region and the operative approach.
PCS Root Operation Considerations
| Clinical Action | PCS Root Operation | Rationale |
|---|---|---|
| Excision of identified sentinel node(s) | Excision (B) | Cutting out a portion of a body part without replacement |
| Injection of tracer/dye to identify lymphatic drainage | Introduction (0) | Putting in/on a therapeutic or diagnostic substance |
| Intraoperative lymphatic drainage mapping visualization | Inspection (J) | Visually/manually exploring a body region (rarely coded separately in this context) |
Common PCS Codes for SLN Excision by Body Region
| PCS Code | Description | Primary Tumor Context |
|---|---|---|
07B60ZX | Excision of Right Axillary Lymphatic, Open, Diagnostic | Right breast cancer, right upper extremity melanoma |
07B70ZX | Excision of Left Axillary Lymphatic, Open, Diagnostic | Left breast cancer, left upper extremity melanoma |
07B10ZX | Excision of Right Neck Lymphatic, Open, Diagnostic | Head/neck or thyroid malignancy |
07B20ZX | Excision of Left Neck Lymphatic, Open, Diagnostic | Head/neck or thyroid malignancy |
07BA0ZX | Excision of Right Inguinal Lymphatic, Open, Diagnostic | Right lower extremity melanoma, vulvar CA, penile CA |
07BB0ZX | Excision of Left Inguinal Lymphatic, Open, Diagnostic | Left lower extremity melanoma, vulvar CA |
07B90ZX | Excision of Pelvic Lymphatic, Open, Diagnostic | Endometrial CA, cervical CA, prostate CA (pelvic SLN) |
Qualifier X - Diagnostic
The qualifier X (Diagnostic) in the 7th character position is critical for SLN biopsy. It documents that the excision is being performed to obtain a tissue specimen for diagnostic analysis (pathologic evaluation), distinguishing it from a therapeutic lymphadenectomy. Always code the qualifier as X (Diagnostic) for sentinel node biopsy procedures. Failure to use the diagnostic qualifier may result in incorrect DRG grouping.
PCS Character Analysis - 07B60ZX (Right Axillary SLN)
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 0 | Medical and Surgical |
| 2 | Body System | 7 | Lymphatic and Hemic Systems |
| 3 | Root Operation | B | Excision |
| 4 | Body Part | 6 | Lymphatic, Right Axillary |
| 5 | Approach | 0 | Open |
| 6 | Device | Z | No Device |
| 7 | Qualifier | X | Diagnostic |
📝 Coding Examples
Example 1 - Outpatient: Left Breast Cancer with Left Axillary SLN Mapping (Negative Node)
Clinical Scenario: A 49-year-old female with invasive ductal carcinoma of the left breast, upper outer quadrant (C50.412), undergoes left partial mastectomy (lumpectomy) with intraoperative SLN mapping. Isosulfan blue dye was injected periareolarly and a handheld gamma counter was used following preoperative Tc-99m injection by nuclear medicine. Two sentinel nodes identified and excised. Final pathology: both nodes negative for malignancy. No axillary lymphadenectomy performed.
| Field | Code | Rationale |
|---|---|---|
| CPT - Primary | 19301--LT | Partial mastectomy, left breast; laterality specified |
| CPT - Add-on | +38900 | SLN mapping; add-on, no modifier -51 |
| PDx | C50.412 | Malignant neoplasm, upper outer quadrant, left breast |
| SDx | Z17.0 | ER-positive status (if documented; supports clinical decision-making) |
| SDx | Z79.01 | Long-term use of anticoagulants (if applicable) |
Note:
Because the SLN is negative, no C77.x code is assigned. Do not code suspected or potential metastatic disease. Nuclear medicine lymphoscintigraphy (78195) is separately reported by the nuclear medicine department under a different NPI.
Example 2 - Outpatient ASC: Melanoma of Right Thigh with Inguinal SLN Mapping (Positive Node)
Clinical Scenario: A 62-year-old male with malignant melanoma of the right thigh (C43.71) undergoes wide local excision with intraoperative right inguinal SLN mapping using methylene blue dye only (no radiotracer). One sentinel node identified with blue dye. Frozen section positive for melanoma metastasis. Surgeon converts to right superficial inguinal lymphadenectomy in the same operative session. Final path: 1 of 12 nodes positive.
| Field | Code | Rationale |
|---|---|---|
| CPT - Primary | 11606--RT | Excision of malignant skin lesion >4.0 cm, right lower extremity |
| CPT - Lymphadenectomy | 38740--RT | Superficial inguinal lymphadenectomy; performed after positive SLN |
| CPT - SLN | ❌ Do NOT report 38900 | SLN mapping subsumed by completion lymphadenectomy 38740 |
| PDx | C43.71 | Malignant melanoma, right lower limb including hip |
| SDx | C77.4 | Secondary malignant neoplasm, inguinal/lower limb nodes (confirmed positive SLN) |
Key Teaching Point
This example illustrates the most common 38900 bundling error in practice. When the sentinel node is positive and the surgeon proceeds to a completion lymphadenectomy in the same operative session, 38900 is NOT separately reported — it is bundled into 38740. Report only the lymphadenectomy. The SLN mapping is considered part of the intraoperative decision-making leading to the definitive procedure.
Example 3 - Outpatient: Endometrial Carcinoma with Bilateral Pelvic SLN Mapping (da Vinci Robotic)
Clinical Scenario: A 58-year-old female with endometrial carcinoma, endometrium (C54.1), undergoes robotic-assisted total hysterectomy, bilateral salpingo-oophorectomy, and bilateral pelvic SLN mapping using ICG dye with near-infrared fluorescence. The SLN mapping and excision is performed laparoscopically prior to hysterectomy. Both sentinel nodes (right and left) are negative. No pelvic lymphadenectomy performed.
| Field | Code | Rationale |
|---|---|---|
| CPT - Hysterectomy | 58571 | Robotic-assisted laparoscopic total hysterectomy with BSO, uterus ≥250g |
| CPT - SLN | +38900 | Bilateral pelvic SLN mapping; single add-on code regardless of bilateral mapping |
| PDx | C54.1 | Malignant neoplasm of endometrium |
| SDx | Z17.0 | ER-positive status if documented |
| SDx | E11.9 | Type 2 diabetes mellitus if documented (common comorbidity in endometrial CA) |
Notes:
- 38900 is reported once even when bilateral SLN mapping is performed — the code descriptor does not differentiate unilateral from bilateral
- ICG with near-infrared imaging falls under the “non-radioactive dye” component of 38900’s descriptor; no separate code is reported for the ICG or the fluorescence imaging device use
Example 4 - Inpatient: Papillary Thyroid Carcinoma with Cervical SLN Mapping + Total Thyroidectomy
Clinical Scenario: A 44-year-old female is admitted for total thyroidectomy with bilateral central neck dissection and right-sided deep jugular SLN mapping for papillary thyroid carcinoma (C73). SLN mapping identifies 2 hot nodes in the right Level III deep jugular chain, excised and sent to pathology. SLN negative. No further dissection. Concurrent diagnoses: moderate malnutrition (E44.0).
ICD-10-PCS (Inpatient Facility):
| Code | Description |
|---|---|
0GTK0ZZ | Resection of Thyroid Gland, Open (total thyroidectomy) |
07B10ZX | Excision, Right Neck Lymphatic, Open, Diagnostic (SLN) |
07B20ZX | Excision, Left Neck Lymphatic, Open, Diagnostic (central neck dissection, bilateral) |
ICD-10-CM Diagnoses:
| Sequence | Code | Description | CC/MCC / HCC Role |
|---|---|---|---|
| PDx | C73 | Malignant neoplasm of thyroid gland | Drives endocrine malignancy DRG |
| SDx | E44.0 | Moderate protein-calorie malnutrition | CC - upgrades DRG tier |
| SDx | Z17.0 | ER-positive (if applicable) | Clinical documentation |
MS-DRG: 644 - Endocrine Disorders with CC (Without E44.0, this groups to DRG 645 — lower GMLOS and relative weight)
Tip
⚠️ Common Coding Pitfalls
-
Reporting 38900 as a standalone code: This is never correct. 38900 is an add-on code and must always be reported with a primary parent procedure. Claims submitted with 38900 as the only procedure code will be denied.
-
Reporting 38900 when a completion lymphadenectomy is performed: If a positive SLN triggers an immediate full regional lymphadenectomy in the same operative session, 38900 is bundled. Report only the lymphadenectomy code. This is one of the most frequently audited bundling patterns in surgical oncology coding.
-
Applying modifier -51 to 38900: Add-on codes are inherently exempt from the multiple procedure reduction rule. Modifier -51 appended to 38900 is incorrect and unnecessary; some payers will reject the claim or process incorrectly.
-
Confusing 38900 with 78195: The preoperative lymphoscintigraphy (radiotracer injection and gamma camera imaging performed in nuclear medicine) is a separate service reported by nuclear medicine as 78195. The surgeon’s intraoperative use of the probe and any dye injection is 38900. Both may be billed by their respective performing providers — they are distinct and non-duplicative.
-
Failing to assign C77.x when SLN is positive: Confirmed nodal metastasis on final pathology should be coded with the appropriate C77.x secondary malignancy code. This significantly impacts HCC RAF scoring in Medicare Advantage and is frequently undercoded.
-
Over-reporting bilateral: 38900 is reported once per operative session regardless of whether SLN mapping is performed in one or multiple nodal basins bilaterally. The code does not have a bilateral modifier counterpart in this context.
-
Incorrect PCS qualifier — omitting the Diagnostic (X) qualifier: In ICD-10-PCS, sentinel node biopsy must use qualifier X (Diagnostic) in the 7th character. Using qualifier Z (No Qualifier) misrepresents the procedure as therapeutic excision rather than diagnostic biopsy, potentially causing DRG miscalculation.
📎 Sources
AMA CPT 2024 Professional Edition · CMS 2024 Medicare Physician Fee Schedule Final Rule (CMS-1784-F) · CMS-HCC Risk Adjustment Model v28 (2024) · CMS MS-DRG Grouper v41.1 · ICD-10-PCS Official Guidelines for Coding and Reporting FY2024, Section B3 - Root Operations · ICD-10-CM Official Guidelines for Coding and Reporting FY2024, Section I.C.2 - Neoplasm Coding · CCI Edits Table, CMS Q1 2024 · NCCN Clinical Practice Guidelines in Oncology: Breast Cancer v3.2024 · AAPC CPC & CIC Study Curriculum 2024 · Morton DL et al., MSLT-I Sentinel Node Biopsy Trial, NEJM 2014 · Krag DN et al., NSABP B-32 Trial, Lancet Oncol 2010